Covid: Oxford oncologist in plea to government over Evusheld
Dr Lennard Lee wants the government to reconsider rolling out Evusheld for people who are immunosuppressed. Source link
Evusheld
Covid: Evusheld antibody protection ruled out for most vulnerable
The antibody injection had promised a protection boost to those with conditions such as blood cancer. Source link
Evusheld for COVID: Lifesaving and Free, but Still Few Takers
Aug. 1, 2022 – Evusheld, the medication used to prevent COVID-19 infection in patients at high risk, has issues. Namely, supplies of the potentially lifesaving drug outweigh demand. At least 7 million people who are immunocompromised could benefit from it, as could many others who are having cancer treatment, have had a transplant, or are … Read more
AstraZeneca COVID drug neutralizes Omicron sub-variants in study
Data from the study by the Washington University showed the therapy reduced the amount of virus detected in samples of all tested Omicron subvariants in mice lungs, the London-listed drugmaker said on Monday. AstraZeneca said its antibody-based cocktail to prevent and treat COVID-19 was shown to retain neutralising activity against Omicron coronavirus variants, including the … Read more